Suganob, Marites Q.
HRN: 28-32-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/27/2025
01/03/2026
IVT
600mg
Q8
Cellulitis Right Foot
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines